NO20030454L - Composition and method of enhancing tissue elasticity - Google Patents

Composition and method of enhancing tissue elasticity

Info

Publication number
NO20030454L
NO20030454L NO20030454A NO20030454A NO20030454L NO 20030454 L NO20030454 L NO 20030454L NO 20030454 A NO20030454 A NO 20030454A NO 20030454 A NO20030454 A NO 20030454A NO 20030454 L NO20030454 L NO 20030454L
Authority
NO
Norway
Prior art keywords
composition
tissue elasticity
enhancing tissue
enhancing
elasticity
Prior art date
Application number
NO20030454A
Other languages
Norwegian (no)
Other versions
NO20030454D0 (en
Inventor
Thomas F Mitts
Lawrence B Sandberg
Jr Felipe Jimenez
Original Assignee
Connective Tissue Imagineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Application filed by Connective Tissue Imagineering filed Critical Connective Tissue Imagineering
Publication of NO20030454D0 publication Critical patent/NO20030454D0/en
Publication of NO20030454L publication Critical patent/NO20030454L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030454A 2000-05-30 2003-01-29 Composition and method of enhancing tissue elasticity NO20030454L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof
PCT/US2001/017384 WO2001091700A2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Publications (2)

Publication Number Publication Date
NO20030454D0 NO20030454D0 (en) 2003-01-29
NO20030454L true NO20030454L (en) 2003-01-29

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030454A NO20030454L (en) 2000-05-30 2003-01-29 Composition and method of enhancing tissue elasticity

Country Status (7)

Country Link
EP (1) EP1392346A4 (en)
AU (2) AU2001275018B2 (en)
CA (1) CA2415225A1 (en)
IL (1) IL153687A0 (en)
NO (1) NO20030454L (en)
NZ (1) NZ523403A (en)
WO (1) WO2001091700A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (en) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif USE OF PEPTIDES TO INCREASE CELL ADHESION
WO2003030860A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
KR20050033510A (en) * 2001-10-05 2005-04-12 프로사이트 코포레이션 Methods for the treatment of hyperpigmentation of skin
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (en) * 2002-12-20 2004-07-08 Henkel Kgaa Method for the determination of markers of human facial skin
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (en) * 2003-05-12 2007-05-04 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIGNS OF SKIN AGING.
EP1765280A1 (en) * 2004-06-28 2007-03-28 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
CA2652388A1 (en) 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
WO2008100789A2 (en) 2007-02-16 2008-08-21 Benaroya Research Institute At Virginia Mason Compositions and methods for altering elastogenesis
CN103458911B (en) 2011-02-11 2016-02-24 密歇根大学董事会 Peptide combinations and the method being used for the treatment of patient
MX2013010977A (en) 2011-03-31 2013-10-30 Procter & Gamble Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis.
JP2015527630A (en) 2012-06-06 2015-09-17 ザ プロクター アンド ギャンブルカンパニー Cosmetic identification system and method for hair / scalp care composition
FR3116273B1 (en) * 2020-11-17 2023-10-27 Sederma Sa Tetrapeptides, compositions comprising them and their cosmetic use
KR102484277B1 (en) * 2021-11-22 2023-01-04 대한켐텍 주식회사 Manufacturing Method Of Raw Material Composition For Improving Skin Beauty

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (en) * 1997-04-11 1998-10-15 Targor Gmbh Metallocene amino acid and peptide complexes
WO1998047921A1 (en) * 1997-04-21 1998-10-29 Schering Corporation Mammalian cytokines; related reagents and methods
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
EP1054677B1 (en) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
AU784203B2 (en) * 1999-10-29 2006-02-23 Glaxosmithkline Biologicals S.A. Neisserial antigenic peptides

Also Published As

Publication number Publication date
NZ523403A (en) 2005-04-29
WO2001091700A2 (en) 2001-12-06
EP1392346A4 (en) 2006-10-25
AU2001275018B2 (en) 2008-04-03
NO20030454D0 (en) 2003-01-29
IL153687A0 (en) 2003-07-06
CA2415225A1 (en) 2001-12-06
EP1392346A2 (en) 2004-03-03
WO2001091700A8 (en) 2003-11-20
AU7501801A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
DK1339292T3 (en) Composition and method
NO20030454D0 (en) Composition and method of enhancing tissue elasticity
NO20000847L (en) Elastic well cement compositions and methods
NO20013393D0 (en) Well cementing methods and compositions
NO20023693L (en) Device and method of providing content
NO20022622L (en) Method of providing content, device for providing content, and user equipment
NO20013356L (en) Delayed thixotropic cement compositions and methods
NO973046L (en) Elastic well cement compositions and methods
NO973048L (en) Elastic well cement compositions and methods
NO20013193L (en) Method and kit for extracting prion protein
DE60130836D1 (en) Architecture and method for context switching
EE200200328A (en) Composition and Method of Mulch
DK1539224T3 (en) Antimicrobial preparation and method of use
NO20012937L (en) Direct spröytestöpt closure and procedure for this
NO20006604D0 (en) Methods and transdermal compositions for pain relief
NO20031848L (en) Polyurethane elastomer gel insulating composition and use thereof
DK1949936T3 (en) Controlled Release Composition and Method of Preparation thereof
NO20015764L (en) Method and preparation for masking mineral taste
NO20042012L (en) Composition and method of treating diabetes
NO20014793L (en) Selective Network Cheating and Procedure for Performing Selective Network Cheating
NO20022057D0 (en) Method and composition for treating pulmonary diseases
NO20005763D0 (en) DHEA composition and method
NO20021947L (en) Bio-borne matrices, method of preparation and use thereof
DK1061955T3 (en) Polynucleotide composition, method of preparation and use thereof
AU1931602A (en) Cement-containing compositions and method of use

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application